Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | AOC3 | Q16853 | 6/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | HTR2A | P28223 | 3/20 | 0.39 |
| ▸ | HRH1 | P35367 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12319469 | 1.00 | ALDH1A1 (0.53) | ALDH1A1KDM4ETHRBAOC3CYP3A4 | |
| SCHEMBL6689517 | 0.84 | THRB (0.47) | ALDH1A1KDM4ETHRBAOC3CYP3A4 | |
| SCHEMBL12426593 | 0.82 | THRB (0.46) | ALDH1A1KDM4ETHRBAOC3CYP3A4 | |
| SCHEMBL6695667 | 0.82 | THRB (0.46) | ALDH1A1KDM4ETHRBAOC3CYP3A4 | |
| SCHEMBL13235503 | 0.82 | KDM4E (0.52) | ALDH1A1KDM4ETHRBAOC3HTR2A | |
| SCHEMBL12386523 | 0.80 | THRB (0.44) | ALDH1A1KDM4ETHRBAOC3CYP3A4 | |
| SCHEMBL5474344 | 0.79 | THRB (0.57) | ALDH1A1THRBCYP3A4HTR2AHRH1 | |
| SCHEMBL5396533 | 0.79 | THRB (0.57) | ALDH1A1THRBCYP3A4HTR2AHRH1 | |
| SCHEMBL3842608 | 0.79 | THRB (0.57) | ALDH1A1THRBCYP3A4HTR2AHRH1 | |
| SCHEMBL5474351 | 0.79 | THRB (0.57) | ALDH1A1THRBCYP3A4HTR2AHRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9073817-B2 | Efficient process to induce enantioselectivity in procarbonyl compounds | LAURUS LABS PRIVATE LIMITED (IN) | 2015-07-07 | — | — | US | disclosed |
| US-20120264933-A1 | EFFICIENT PROCESS TO INDUCE ENANTIOSELECTIVITY IN PROCARBONYL COMPOUNDS | LAURUS LABS PRIVATE LIMITED (IN) | 2012-10-18 | — | — | US | disclosed |
| US-20080026933-A1 | 1,1'-Diphosphinoferrocenes Having 2,2'-Bound Achiral Or Chiral Radicals | SOLVIAS AG (CH) | 2008-01-31 | — | — | US | disclosed |
| WO-2004082565-A2 | ASYMMETRIC CYCLIZATION IN THE PRESENCE OF SUBSTITUTED PSEUDOPHEDRINES | H. LUNDBECK A/S (DK) | 2004-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080026933-A1 | 1,1'-Diphosphinoferrocenes Having 2,2'-Bound Achiral Or Chiral Radicals | FECH, FDPS, DHPS | ALDH1A1 705/4885KDM4E 1252/4885THRB 4065/4885 |
| US-20120264933-A1 | EFFICIENT PROCESS TO INDUCE ENANTIOSELECTIVITY IN PROCARBONYL COMPOUNDS | OTC, MCCC2, SLC6A5 | ALDH1A1 690/4885KDM4E 1301/4885THRB 4606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.